Latest Genomic Health Inc. Stories
First Kit Improves RNA-Seq for FFPE and High-Quality RNA Samples IPSWICH, Mass., Aug. 19, 2014 /PRNewswire/ -- New England Biolabs, Inc.
REDWOOD CITY, Calif., Aug. 8, 2014 /PRNewswire/ -- Genomic Health, Inc.
17% Increase in Test Volume, 11% Increase in Total Revenue and 29% Increase in International Product Revenue Compared to Prior Year REDWOOD CITY, Calif., Aug.
Study Achieved Primary Endpoint of Predicting Recurrence after Surgery and Reconfirmed Original Adverse Pathology Endpoint from Published UCSF Validation Study REDWOOD CITY, Calif.,
REDWOOD CITY, Calif., July 31, 2014 /PRNewswire/ -- Genomic Health, Inc.
Complete Data to be Submitted for Presentation at the 2014 San Antonio Breast Cancer Symposium REDWOOD CITY, Calif., June 11, 2014 /PRNewswire/ -- Genomic Health, Inc.
Two Studies Presented at ASCO® Demonstrate Company's Ability to Develop Tests to Predict Disease Aggressiveness Across Various Cancers REDWOOD CITY, Calif., June 3, 2014 /PRNewswire/
New Study Shows Oncotype DX® DCIS Score(TM) Changes Treatment Recommendations for One Out of Three DCIS Patients REDWOOD CITY, Calif., June 1, 2014 /PRNewswire/ -- Genomic Health, Inc.
New Data Presented at ASCO® Annual Meeting Suggest that Genomic Health's Oncotype DX Test May Help Identify Patients That Have the Greatest Opportunity to Benefit from Extended Hormonal Therapy
REDWOOD CITY, Calif., May 23, 2014 /PRNewswire/ -- Genomic Health, Inc.
- One of a pair of round metal cymbals attached to the fingers and struck together for rhythm and percussion in belly dancing.